Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2021, 394, 1737–1755. [Google Scholar] [CrossRef] El-Helaly, S.N.; Elbary, A.A.; Kassem...
- Liposome / Microsphere / Nanoparticle - Overview - Liquid - Clinical Supply - Controlled Substance - High Potency APIs (HPAPIs) - Overview - Lyophilization - Overview - Medical Device - Overview - Nasal - Clinical Supply - Inhalation - Overview - Paste - Overview - Patch - Transdermal -...
Daryl Drummond, Merrimack Pharmaceuticals, based on his experience developing nanomaterials for industry, more specifically, novel liposome products. The section identifiers noted in parentheses below refer to the corresponding section in the guidance where this topic is discussed. Dissolution/In Vitro ...